The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)

The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF) - The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)(iDOAC registry)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030673

Enrollment

1000

Registered

2018-01-04

Start date

2017-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Japanese patient with anticoagulant therapy for non valvular atrial fibliration (2)Patient with 20 years old and older (3)Patient signed Informed consent

Exclusion criteria

Exclusion criteria: (1)Patient recieved or will recieve catheter ablation during follow up. (2)Patient recieved catheter ablation for atrial fibliration in the past 6 month. (3)In patient with cancer, not noticed of cancer at the time of informed consent. (4)Patient judged unsuitable for the study by prncipal investigator or subinvetigator

Design outcomes

Primary

Measure	Time frame
We investigate the new events of stroke and/or systemic embolism by the type of anticoagulant and therapy (medicine vs non medicine) during follow-up period of 12M after informed cocent.	—

Secondary

Measure	Time frame
Death(cardiovascular death/non-cardiovascular death), stroke(ischemic/hemorrhagic/unclassified), systemic embolism, cardiovascular event(acute myocardial infarction/unstable angina), hemorrhagic event (intracranial bleeding except hemorrhagic stroke, gastrointestinal bleeding), adverse event, others	—

Countries

Japan

Contacts

Public ContactShingo Maeda

Tokyo Medical and Dental University Heart Rhythm Center

smaecvm@tmd.ac.jp03-5803-5231

Outcome results